Sara Gaafar Ibnauf Suliman: The Changing Role of Bariatric Surgery in the GLP-1 Era
Sara Gaafar Ibnauf Suliman, President of Obesity Medicine Section at IFSO International Federation for the Surgery and other therapies for Obesity (IFSO), shared a post on LinkedIn:
“GLP1 receptor agonist usage has expanded exponentially, making some question the role of metabolic bariatric surgery (MBS) in the management of obesity.
In this article published today in the The Lancet Obstetrics, Gynaecology, and Women’s Health we present a balanced view on why both MBS and GLP1RAs have an important role to play in the management of obesity and particularly in women.”
Title: Obesity medications in women’s health: is metabolic bariatric surgery still relevant?
Authors: Sara G I Suliman, Ali Aminian, Mohammed Al-Hadad, Alexander Dimitri Miras, Dimitris Papamargaritis, Melanie J Davies, Susan E Ozanne, Claire L Meek, Tricia M-M Tan

Stay updated with Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?